Détail de l'auteur
Auteur E. DRAPALOVA |
Documents disponibles écrits par cet auteur (4)
Ajouter le résultat à votre sélection Faire une suggestion Affiner la recherche
NouveautéV. BELACKOVA ; M. PAZITNY ; E. DRAPALOVA ; M. MARTINEZ ; D. VAN DER GOUWE ; E. BEGLEY ; M. KIDAWA ; A. TOMKOVA ; D. KMETONYNOVA | 2018
Dans Drugs: Education, Prevention and Policy (Vol.25, n°2, April 2018) Article : PériodiqueAims: The indicator of availability has been used in the risk assessment (RA) of new psychoactive substances (NPS). This paper aims to examine the pre- and post-control availability of 25I-NBOMe, AH-7921, MDPV and MXE, which were assessed by the[...]E. DRAPALOVA ; V. BELACKOVA ; D. CALADO ; A. VAN DONGEN ; I. PANEVA ; R. PAVARIN ; E. POLIDORI ; J. P. GRUND | 2019
Dans Substance Use and Misuse (Vol.54, n°10, 2019) Article : PériodiqueBackground: Timely information about trends in psychoactive substance use could yield tailored interventions and reduce potential harms. However, conventional epidemiological tools might have limited capacity to detect trends emerging on a local[...]E. DRAPALOVA ; V. BELACKOVA ; A. CADET-TAÏROU | 2020
Dans Drug and Alcohol Review (Vol.39, n°3, March 2020) Article : PériodiqueIntroduction and Aims: New psychoactive substances (NPS) represent hundreds of novel compounds. However, the general public might not be familiar with the overarching term NPS. This can result in both under- and over-reporting of NPS use. Desig[...]This paper provides a narrative review of the existing literature around online survey methods and their specific application in the area of illicit drug use. A search of relevant databases (Google Scholar, EBSCO, ProQuest) was conducted in orde[...]